(FATE) - Earnings & Price History

FATE: - 4.65, $196.31M, -0.12 (-2.52%)

Sector: Healthcare - Industry: Biotechnology

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops programmed cellular immunotherapies for cancer and immune disorders in the United States. Its novel ex vivo cell programming approach applies to modulate the therapeutic function and direct the fate of immune cells. The companys lead product candidate is ProTmune, a programmed immuno-regulatory cell therapy that is in clinical development stage for the prevention of acute graft-versus-host disease and cytomegalovirus infection in immunocompromised patients undergoing allogeneic hematopoietic cell transplantation. Its preclinical programs include NK- and T-cell cancer immunotherapies, such as off-the-shelf therapies derived from engineered induced pluripotent cells comprising iNK cell therapy and iT cell therapy; and a CD34+ cell immuno-regulatory therapy to suppress aberrant auto-reactive effector

Past FATE reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-01-0.294.294.384.454.194.451.60%-3.60%-2.05%241.22K
2016-11-04-0.29
2016-11-03-0.291.951.921.821.811.99-5.21%▲7.14%1.56%56.07K
2016-11-02-0.291.922.032.011.82.03-0.99%▲-4.48%-5.42%139.36K
2016-11-01-0.292.02992.082.0822.134-2.41%-2.41%28.41K
2016-08-05-0.32
2016-08-04-0.322.112.082.082.062.141.44%1.44%150.06K
2016-08-03-0.322.082.062.082.042.090.97%0.97%135.38K
2016-05-06-0.25
2016-05-05-0.251.711.691.671.631.76-1.18%2.40%1.18%102.16K
2016-03-03-0.271.971.831.881.882.232.73%4.79%7.65%1.32M
2015-08-05-0.396.976.876.916.917.390.58%0.87%1.46%66.43K
2015-05-07-0.377.227.196.876.877.83-4.45%5.09%0.42%213.10K
2014-11-11AMCFate Therapeutc-0.29-0.34.043.95444.291.27%▲1.00%2.28%41.90K
2014-08-12AMCFate Therapeutc-0.36-0.35.5165.75.35.98-5.00%-3.33%-8.17%66.30K
2014-05-13AMCFate Therapeutc-0.32-0.346.556.566.626.546.980.91%-1.06%-0.15%8.60K
2014-03-17AMCFate Therapeutc-0.2911.5110.4310.4510.2111.60.19%10.14%10.35%94.50K
2013-11-13AMCFate Therapeutc-0.37-4.814.865.164.974.55.05-3.68%▲-2.21%-5.81%72.70K

Login | Register
Saturday Nov 17, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades